Literature DB >> 15481076

The relationship between non-cognitive symptoms and functional impairment in Alzheimer's disease.

W Y W Mok1, L W Chu, C P Chung, N Y Chan, S L Hui.   

Abstract

OBJECTIVE: Cognitive impairment is an important determinant for functional impairment in Alzheimer's disease. The role of non-cognitive symptom is uncertain. The objective of this study was to investigate the role of non-cognitive symptoms as predictive factors for functional outcome in A.D.
METHODS: This was a retrospective study. Subjects were recruited from the Memory Clinic in Queen Mary Hospital over a two years period. Patients with diagnosis of probable A.D. by NINCDS-ADRDA were identified. Demographic data, Folstein Mini-Mental Status Examination (MMSE), Clinical Dementia Rating (CDR), Neuropsychiatric inventory (NPI), Barthel activities of daily living (ADL) as well as Lawton's Instrumental activities of daily living (IADL) were retrieved.
RESULTS: 100 patients were identified. Univariate analysis identified statistically significant correlation between hallucination and disinhibition score with Barthel Index (r=-0.43, p <0.001; r=-0.30, p=0.002 respectively); hallucination and aberrant motor act score with Lawton's IADL (r=-0.21, p=0.038; r=-0.21, p=0.038). MMSE was statistical significantly correlated with the above two functional scores. NPI was not statistical significantly correlated with any one of the functional measures. Multivariate regression analyses showed that hallucination score was an independent predictive factors for the Barthel index but not for the Lawton's IADL. MMSE score was identified to be independent predictive factor for all functional measures.
CONCLUSIONS: Global cognitive impairment and hallucination was an important independent predictive factor for functional outcomes. Screening hallucination during the course of A.D. would be helpful. Further studies are needed to show the benefit of treatment of hallucination on the improvement of functional outcomes.

Entities:  

Mesh:

Year:  2004        PMID: 15481076     DOI: 10.1002/gps.1207

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  12 in total

1.  Prevalence of neuropsychiatric symptoms and their association with functional limitations in older adults in the United States: the aging, demographics, and memory study.

Authors:  Toru Okura; Brenda L Plassman; David C Steffens; David J Llewellyn; Guy G Potter; Kenneth M Langa
Journal:  J Am Geriatr Soc       Date:  2010-01-26       Impact factor: 5.562

2.  Executive Dysfunction and Behavioral Symptoms Are Associated with Deficits in Instrumental Activities of Daily Living in Frontotemporal Dementia.

Authors:  Negar Moheb; Mario F Mendez; Sarah A Kremen; Edmond Teng
Journal:  Dement Geriatr Cogn Disord       Date:  2017-01-20       Impact factor: 2.959

3.  A comparison of end-stage renal disease and Alzheimer's disease in the elderly through a comprehensive geriatric assessment.

Authors:  Pinar Soysal; Ahmet Turan Isik; Banu Buyukaydin; Rumeyza Kazancioglu
Journal:  Int Urol Nephrol       Date:  2014-05-22       Impact factor: 2.370

4.  "Noncognitive" symptoms of early Alzheimer disease: a longitudinal analysis.

Authors:  Mary Clare Masters; John C Morris; Catherine M Roe
Journal:  Neurology       Date:  2015-02-10       Impact factor: 9.910

5.  Neuropsychiatric correlates of white matter hyperintensities in Alzheimer's disease.

Authors:  Yosef A Berlow; William M Wells; James M Ellison; Young Hoon Sung; Perry F Renshaw; David G Harper
Journal:  Int J Geriatr Psychiatry       Date:  2010-08       Impact factor: 3.485

6.  Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum.

Authors:  Lauren P Wadsworth; Natacha Lorius; Nancy J Donovan; Joseph J Locascio; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Gad A Marshall
Journal:  Dement Geriatr Cogn Disord       Date:  2012-08-28       Impact factor: 2.959

7.  Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment.

Authors:  Manuel Fernández; Ana L Gobartt; Montse Balañá
Journal:  BMC Neurol       Date:  2010-09-28       Impact factor: 2.474

8.  The Effect of Type 2 Diabetes Mellitus on Neuropsychological Symptoms in Chinese Early Alzheimer's Disease Population.

Authors:  Qianqian Shi; Faying Zhou; Jing Mei; Haimei Yang; Huiyun Li
Journal:  Neuropsychiatr Dis Treat       Date:  2020-03-26       Impact factor: 2.570

9.  IDE Gene Polymorphism Influences on BPSD in Mild Dementia of Alzheimer's Type.

Authors:  Noriko Sato; Akinori Ueki; Hideo Ueno; Hidetaka Shinjo; Yoshio Morita
Journal:  Curr Gerontol Geriatr Res       Date:  2008-12-04

Review 10.  Synchronizing an aging brain: can entraining circadian clocks by food slow Alzheimer's disease?

Authors:  Brianne A Kent
Journal:  Front Aging Neurosci       Date:  2014-09-01       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.